Dr. Jesus Berdeja
Dr. Berdeja serves as the Director of Myeloma Research at the Sarah Cannon Research Institute and is a partner at Tennessee Oncology. He has been certified a Diplomate in internal medicine, medical oncology, and hematology by the American Board of Internal Medicine. Dr. Berdeja is an active researcher and has been the principal investigator on a number of funded trials relating to the management of multiple myeloma, lymphoma, and other hematologic malignancies.
